In this regard, the role of the incretin hormone GLP-1 has been specifically and extensively investigated, mainly in consideration that the GLP-1 system has become a target for the treatment of type 2 diabetes (Drucker and Nauck, 2006). Here, GCG is linked to type 2 diabetes mellitus.